Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001104659-26-124003·BAKER BROS. ADVISORS LP
Schedule 13D ownership disclosure
Madrigal Pharmaceuticals Inc
Common Stock, $0.0001 par value per share · CUSIP: 558868105
Event date: 2026-11-06
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Baker Bros. Advisors LPReported CIK 0001263508
Shares: 2,330,144.00 · Class: 9.99%
- Baker Bros. Advisors (GP) LLCReported CIK 0001580575
Shares: 2,330,144.00 · Class: 9.99%
- Julian C. BakerReported CIK 0001087939
Shares: 2,330,144.00 · Class: 9.99%
- Felix J. BakerReported CIK 0001087940
Shares: 2,330,144.00 · Class: 9.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-26-124003
- Form type
- SCHEDULE 13D/A
- Filer
- BAKER BROS. ADVISORS LP
- CIK
- CIK 1263508
- Filed
- Nov 06, 2026
- Reporting period
- Nov 06, 2026
- Description
- Schedule 13D beneficial ownership